tiprankstipranks
Advertisement
Advertisement
Tonix Pharma Highlights Positive Phase 3 Fibromyalgia Data
PremiumCompany AnnouncementsTonix Pharma Highlights Positive Phase 3 Fibromyalgia Data
18d ago
Tonix Pharmaceuticals publishes TNX-102 SL data in journal
Premium
The Fly
Tonix Pharmaceuticals publishes TNX-102 SL data in journal
23d ago
Tonix Pharma Uplists to Nasdaq Global Select Market
Premium
Company Announcements
Tonix Pharma Uplists to Nasdaq Global Select Market
25d ago
Tonix Pharma advances TNX-4800 Lyme disease program
PremiumCompany AnnouncementsTonix Pharma advances TNX-4800 Lyme disease program
3M ago
Tonix prices 615,025 shares at $16.26 in registered direct offering
Premium
The Fly
Tonix prices 615,025 shares at $16.26 in registered direct offering
3M ago
Tonix Pharmaceuticals announces update on Phase 2/3-ready TNX-4800
Premium
The Fly
Tonix Pharmaceuticals announces update on Phase 2/3-ready TNX-4800
3M ago
Tonix Pharma’s IND Clearance Boosts MDD Treatment Efforts
PremiumCompany AnnouncementsTonix Pharma’s IND Clearance Boosts MDD Treatment Efforts
4M ago
Tonix Pharmaceuticals receives IND clearance for Phase 2 study of TNX-102 SL
Premium
The Fly
Tonix Pharmaceuticals receives IND clearance for Phase 2 study of TNX-102 SL
4M ago
Tonix Pharma Amends Sales Agreement to Raise Capital
Premium
Company Announcements
Tonix Pharma Amends Sales Agreement to Raise Capital
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100